# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
The reverse stock split will become effective at 12:02 a.m., Eastern Time on December 18, 2023.
Gainers
The reverse stock split will become effective at 12:01 a.m. Eastern time on September 25, 2023.
Privately-held Neurogene Inc has agreed to merge with Neoleukin Therapeutics Inc (NASDAQ: NLTX) in
The combined company is expected to operate under the name Neurogene Inc. and trade on the Nasdaq Capital Market under the tick...
Mizuho analyst Mara Goldstein maintains Neoleukin Therapeutics (NASDAQ:NLTX) with a Neutral and lowers the price target from...
U.S. stocks turned lower toward the end of trading, with the Dow Jones dropping around 300 points on Thursday. The Dow traded ...